P. Ponzani

[Is it possible to prevent andrological complications in the diabetic patient?].

R. Quadri, M. Zanone, S. Maule, P. Ponzani +1 more

1991Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences2 citations

Semantic Scholar

P. Ponzani

Most-cited papers

Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells.

Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome.

Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I.

Artificial Intelligence and Big Data in Diabetes Care: A Position Statement of the Italian Association of Medical Diabetologists

Long-term effectiveness and safety of liraglutide in clinical practice.

Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.

Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes

Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis

Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study

Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture.

Assessment of growth hormone insulin like growth factor-I axis in Down’s syndrome

Changes in autonomic nervous function over a 5-year period in non-insulin-dependent diabetic patients.

Effectiveness and safety of liraglutide after three years of treatment.

Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group

Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa

Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis

Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

Failure to increase insulin‐like growth factor‐I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders

Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety

Functions and regulation of the acid-labile subunit of the 150 K complex.

QUALITY OF LIFE AND TREATMENT SATISFACTION IN PATIENTS WITH TYPE 1DIABETES: A COMPARISON BETWEEN CONTINUOUS SUBCUTANEOUS INSULININJECTION AND MULTIPLE DAILY INJECTIONS

Achieving Good Metabolic Control Without Weight Gain with the Systematic Use of GLP-1-RAs and SGLT-2 Inhibitors in Type 2 Diabetes: A Machine-Learning Projection Using Data from Clinical Practice.

Incretin-based therapies in clinical practice: from efficacy to effectiveness. Focus on liraglutide.

[Is it possible to prevent andrological complications in the diabetic patient?].

Insulin-like growth factors (IGF-I and IGF-II)and IGFBP-3 in patients with Turner syndrome: in vivo and in vitro studies.

The role of logic learning machine in predicting lipid goal attainment among type 2 diabetes outpatients: Results from the AMD annals study group

Insulin DEgludec in hospitalized patients with type 2 diabetes (IDEOS Study): what effects on glycemic control, glycemic variability and hypoglycemia

Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly.

GROWTH HORMONE AND ESTROGENS IN PATIENTS WITH TURNER SYNDROME: IN VIVO AND IN VITRO STUDIES